Infectious Disease

• Regulatory

GSK eyes October FDA verdict on chronic hep B drug

pharminent April 28, 2026

• Regulatory

UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention

pharminent April 27, 2026

• Clinical Data

Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial

pharminent April 22, 2026

• Clinical Data

Pivotal trial of Moderna’s H5N1 bird flu jab gets underway

pharminent April 22, 2026

• Regulatory

MSD secures EC approval for Enflonsia to prevent infant RSV infection

pharminent April 20, 2026

• Policy / Pricing

Scientists issue call to arms over antifungal resistance

pharminent April 15, 2026

• M&A / Deals

Shionogi secures $482m BARDA contract to tackle AMR crisis

pharminent April 9, 2026

• Policy / Pricing

EU invests 30m to fight antimicrobial resistance

pharminent April 8, 2026

• Clinical Data

Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment

pharminent April 2, 2026

• Regulatory

Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results

pharminent March 23, 2026